Theranostics Market - By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarkers Screening, Software & Services), By Application (Prostate Cancer, Neuroendocrine Cancer,......Adult Pheochromocytoma, Others), By End Users (Hospitals, Diagnostic Centers) and others Read more
- Healthcare
- May 2024
- 199
- PDF, Excel, PPT
Market Definition
Theranostics is an integrated approach combining diagnostic and therapeutic capabilities within a single platform, enabling personalized medicine strategies. It involves the use of diagnostic techniques to identify biomarkers or molecular targets associated with specific diseases, guiding the selection of targeted therapies tailored to individual patients.
Market Insights & Analysis: Global Theranostics Market (2024-30):
The Global Theranostics Market size is estimated to grow at a CAGR of around 14.4% during the forecast period, i.e., 2024-30. The market for theranostics has been growing at a significant rate during the past few years, owing to several key factors. The increasing number of hospitals, along with a growing emphasis on targeted therapies, has been contributing to this market expansion. Moreover, the introduction of innovative theranostics approaches in recent years has further escalated market growth & development.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2019-22 |
| Base Year: 2023 | |
| Forecast Period: 2024-30 | |
| CAGR (2024-2030) | 14.4% |
| Regions Covered | North America: US, Canada, Mexico |
| Europe: Germany, The UK, France, Spain, Italy, Rest of Europe | |
| Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific | |
| South America: Brazil, Argentina, Rest of South America | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA | |
| Key Companies Profiled | Siemens Healthcare Private Limited, GE HealthCare, Bayer AG, Cardinal Health, Hologic, Inc., Radiopharm Theranostics Limited, ITM Isotope Technologies Munich SE, Isotopia Molecular Imaging, Perspective Therapeutics, Ratio Therapeutics, ChiRhoClin, Cerebral, Therapeutics, Inc., Telix Pharmaceuticals Limited, Biosynth Ltd., Theradiag, Others |
| Unit Denominations | USD Million/Billion |
Additionally, a significant contributor to market growth has been the integration of artificial intelligence (AI) in diagnostics, which has been enhancing its accuracy and efficiency. Furthermore, recent FDA approvals have heightened awareness and bolstered the adoption of theranostics, paving the way for personalized medicine practices. Personalized medicine is an innovative approach that ensures that treatments are optimized based on the unique molecular and cellular profiles of each patient, leading to improved outcomes and reduced side effects. Thus, theranostics, by combining diagnostics and therapy, has enabled individualized and targeted treatment strategies. Also, in the realm of cancer management, theranostics and precision medicine have played pivotal roles, allowing healthcare professionals to identify specific biomarkers and tailor treatments accordingly, thereby increasing treatment success rates.
Further, developing countries, such as India and China, present significant growth opportunities for market players despite cost concerns. The sizable population base in these regions offers a sustainable market for theranostics, driven by the pressing need for early detection and management of chronic diseases like cancer, strokes, and cardiovascular diseases. Hence, as companies in the theranostics market are making efforts to expand across developing countries, it would help in the overall market growth during the forecast period.
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumptions
- Executive Summary
- Global Theranostics Market Patent Analysis
- Global Theranostics Market Clinical Trial Analysis
- Global Theranostics Market Trends & Insights
- Global Theranostics Market Dynamics
- Drivers
- Challenges
- Global Theranostics Market Hotspots & Opportunities
- Global Theranostics Market Supply Chain Analysis
- Global Theranostics Market Regulations & Policies
- Global Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product
- Diagnostic Imaging- Market Size & Forecast 2019-2030F, USD Million
- MRI- Market Size & Forecast 2019-2030F, USD Million
- Pet Imaging- Market Size & Forecast 2019-2030F, USD Million
- Nuclear Imaging- Market Size & Forecast 2019-2030F, USD Million
- Others (CT Scan, Molecular Imaging, etc.)- Market Size & Forecast 2019-2030F, USD Million
- Radiopharmaceuticals- Market Size & Forecast 2019-2030F, USD Million
- Lutetium-177- Market Size & Forecast 2019-2030F, USD Million
- Samarium-153- Market Size & Forecast 2019-2030F, USD Million
- Radium-223- Market Size & Forecast 2019-2030F, USD Million
- Iodine-131- Market Size & Forecast 2019-2030F, USD Million
- Yttrium-90- Market Size & Forecast 2019-2030F, USD Million
- Others (Gallium-68 Fluorine-18, etc.) - Market Size & Forecast 2019-2030F, USD Million
- IVD/Biomarkers Screening- Market Size & Forecast 2019-2030F, USD Million
- Polymerase Chain Reaction- Market Size & Forecast 2019-2030F, USD Million
- Next-Generation Sequencing (NGS)- Market Size & Forecast 2019-2030F, USD Million
- Fluorescence in-situ Hybridization (FISH)- Market Size & Forecast 2019-2030F, USD Million
- Software & Services- Market Size & Forecast 2019-2030F, USD Million
- Diagnostic Imaging- Market Size & Forecast 2019-2030F, USD Million
- By Application
- Prostate Cancer- Market Size & Forecast 2019-2030F, USD Million
- Neuroendocrine Cancer- Market Size & Forecast 2019-2030F, USD Million
- Adult Pheochromocytoma- Market Size & Forecast 2019-2030F, USD Million
- Others (Paraganglioma, Pediatric Neuroblastoma, etc.)- Market Size & Forecast 2019-2030F, USD Million
- By End Users
- Hospitals- Market Size & Forecast 2019-2030F, USD Million
- Diagnostic Centers- Market Size & Forecast 2019-2030F, USD Million
- Others (Research Institutes and Academic Centers, Specialty Clinics, etc.)- Market Size & Forecast 2019-2030F, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
- By Company
- Market Share of Top Companies
- Competition Characteristics
- By Product
- Market Size & Analysis
- North America Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- The US
- Canada
- Mexico
- The US Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Canada Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Mexico Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- South America Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- Brazil
- Argentina
- Rest of South America
- Brazil Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Argentina Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Europe Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Germany Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- The UK Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- France Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Italy Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Spain Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- The Middle East & Africa Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- Saudi Arabia
- The UAE
- South Africa
- Rest of the Middle East & Africa
- Saudi Arabia Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- The UAE Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- South Africa Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Asia Pacific Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By Application- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- China Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Japan Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- India Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- South Korea Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Australia Theranostics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030F, USD Million
- By End Users- Market Size & Forecast 2019-2030F, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Global Theranostics Market Key Strategic Imperatives for Growth & Success
- Competition Outlook
- Company Profiles
- Siemens Healthcare Private Limited
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- GE HealthCare
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Bayer AG
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Cardinal Health
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Hologic, Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Radiopharm Theranostics Limited
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- ITM Isotope Technologies Munich SE
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Isotopia Molecular Imaging
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Perspective Therapeutics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Ratio Therapeutics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- ChiRhoClin
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Cerebral Therapeutics, Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Telix Pharmaceuticals Limited
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Biosynth Ltd.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Theradiag
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Siemens Healthcare Private Limited
- Company Profiles
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making
FILL THE FORM TO GET THE FREE SAMPLE PAGES